biology

Bioptimus raises $35 million seed round to develop AI foundational model focused on biology

There’s a new generative AI startup based in Paris. But what makes Bioptimus interesting is that it plans to apply everything we’ve collectively learned about AI models over the past few years wit

Puna Bio’s extremophile microbe menagerie survives and revives depleted soil

The farming industry spends tons of money on artificial means of reinvigorating soil, but an all-natural solution may already exist: beneficial microbes that have evolved to thrive in extreme environm

Digital biomarkers are healthcare’s next frontier

Historically, continuous tracking of an individual’s vital signs meant they had to be in a hospital. But that's not true anymore.

NovaXS Biotech wants to make injection therapy needle-free

A startup spawned from a lab at the University of California, Berkeley has won investor support to work on its patented needle-free injector, which it hopes can make therapies that traditionally requi

Dawn Health leverages cognitive behavioral therapy for insomnia to help you sleep better

The mobile app offers evidence-based therapy integrated with a sleep tracker, access to a sleep coach and personalized daily lesson plans.

Startup Battlefield winner Cellino grabs $80M Series A

Cellino Bio’s founder Nabiha Saklayen didn’t initially intend to enter TechCrunch Disrupt 2021’s Startup Battlefield — it was her PR advisor who threw the startup’s name in the ring as a

Phytoform plants $5.7M into climate-resistant crop technology

The success of CRISPR technology in agriculture has been well documented as a way to manipulate plant genomes to make them more pest and climate resistant and grow more consistent products.

Nabla Bio raises $11M for an “end-to-end” antibody design platform

Nabla Bio, a Boston, Massachusetts based startup, announced a $11 million seed round on Monday. The company, founded in May 2020, is looking to enter the increasingly competitive space of antibody des

Generate Biomedicines raises $370M Series B with a focus on protein-based drugs

The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round.  Generate Biomedicines

Flagship Pioneering’s new venture is betting on tRNA to treat ‘thousands of diseases’

On Tuesday, Flagship Pioneering, the major investor behind Moderna, announced yet another addition to their portfolio of RNA-curious companies. Following a year of hype around mRNA, a new company, cal

AgBiome lands $116M for safer crop protection technology

The company captures diverse microbes for agricultural applications, like crop protection, and screens strains for the best assays that would work for insect, disease and nematode control.

Personalized nutrition startup Zoe closes out Series B at $53M total raise

Personalized nutrition startup Zoe — named not for a person but after the Greek word for ‘life’ — has topped up its Series B round with $20M, bringing the total raised to $53M.

I can’t believe it’s not meat! Mycelium meat replacement company aims for summer launch of first products

Meati, a company turning mycelium (the structural fibers of fungi) into healthier meat replacements for consumers, is prepping for a big summer rollout. Co-founder Tyler Huggins expects to have the fi

Mercado Libre taps Pachama to monitor and manage its $8 million investment in Latin American rainforest restoration

Mercado Libre, one of the largest e-commerce and financial services company from Latin America by market cap, has selected the startup and Y Combinator alumni Pachama as its strategic partner in devel

New clinical trial data from Locus Biosciences shows promise in CRISPR-Cas3 technology

Antibiotic resistance is one of the biggest potential threats to global health today. But Locus Biosciences is hoping that their crPhage technology might provide a new solution. Based in North Carolin

Senti Bio raises $105 million for its new programmable biology platform and cancer therapies

Senti Biosciences, a company developing cancer therapies using a new programmable biology platform, said it has raised $105 million in a new round of financing led by the venture arm of life sciences

23andMe raises $82.5 million in new funding

DNA testing technology company 23andMe has raised just shy of $82.5 million in new funding, from an offering of $85 million in total equity shares, according to a new SEC filing. The funding, confirme

Poland’s GeneMe secures €5.2M seed funding for its rapid COVID-19 test

GeneMe, Poland-based biotechnology company with a COVID-19 test, has secured a €5.2 million round of seed funding led by Robin Tombs, co-founder of Yoti and previously of Gamesys, and other angel in

John Legend and Natalie Portman want you to try wearing fungus instead of leather

Natalie Portman and John Legend are joining a group of venture capitalists and unnamed fashion brands backing MycoWorks, a company that just raised $45 million to commercialize its technology that mak

Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo Day

Biotech can often, and sometimes literally, fly over our heads. However, the pandemic has shown an increased need for investment and focus on solutions that work on human and planetary health. For Ind
Load More